Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jan GlaxoSmithKline Biologicals S.A. Poolman is active.

Publication


Featured researches published by Jan GlaxoSmithKline Biologicals S.A. Poolman.


Archive | 2003

Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria minigitidis

Ralph Biemans; Philippe Denoel; Christiane GlaxoSmithKline Biologicals s.a Feron; Carine Goraj; Jan GlaxoSmithKline Biologicals S.A. Poolman; Vincent GlaxoSmithKline Biologicals s.a Weynants


Archive | 2001

Vaccine against streptococcus pneumoniae

Philippe Hermand; Craig Antony Joseph Laferriere; Yves GlaxoSmithKline Beecham Biologicals Lobet; Jan GlaxoSmithKline Biologicals S.A. Poolman


Archive | 2003

Neisserial vaccine compositions comprising a combination of antigens

Francois-Xavier Jacques GlaxoSmithKline Berthet; Ralph Biemans; Philippe Denoel; Christiane GlaxoSmithKline Biologicals s.a Feron; Carine Goraj; Jan GlaxoSmithKline Biologicals S.A. Poolman; Vincent GlaxoSmithKline Biologicals s.a Weynants


Archive | 2003

Vaccine composition comprising lipooligosaccharide with reduced phase variability

Ralph Biemans; Philippe Denoel; Christiane GlaxoSmithKline Biologicals s.a Feron; Carine Goraj; Michael Paul Jennings; Jan GlaxoSmithKline Biologicals S.A. Poolman; Vincent GlaxoSmithKline Biologicals s.a Weynants


Archive | 2001

Mimotope of neisseria meningitides lipooligosaccharide and vaccines containing the same

Bolle Xavier Thomas Laboratoire d'Immunologie De; Jean-jacques Letesson; Yves GlaxoSmithKline Biologicals S.A. Lobet; Pascal Yvon Mertens; Jan GlaxoSmithKline Biologicals S.A. Poolman; Pierre GlaxoSmithKline Biologicals s.a. Voet


Archive | 2004

Pertussis antigens and use thereof in vaccination

Cindy Castado; Philippe Denoel; Fabrice Godfroid; Jan GlaxoSmithKline Biologicals S.A. Poolman


Archive | 2004

B. pertussis antigene und ihre verwendung bei der vakzinierung

Cindy Castado; Philippe Denoel; Fabrice Godfroid; Jan GlaxoSmithKline Biologicals S.A. Poolman


Archive | 2003

Neisseria impfstoffzusammensetzungen die eine kombination von antigenen enthalten

Francois-Xavier Jacques GlaxoSmithKline Berthet; Ralph Biemans; Philippe Denoel; Christiane GlaxoSmithKline Biologicals s.a Feron; Carine Goraj; Jan GlaxoSmithKline Biologicals S.A. Poolman; Vincent GlaxoSmithKline Biologicals s.a Weynants


Archive | 2003

Impfstoffzusammensetzung die transferrin bindende protein und hsf aus gram-negativen bakterien enthält

Francois-Xavier Jacques GlaxoSmithKline Berthet; Ralph GlaxoSmithKline Biol. S.A. Biemans; Philippe Denoel; Christiane GlaxoSmithKline Biologicals s.a Feron; Carine Goraj; Jan GlaxoSmithKline Biologicals S.A. Poolman


Archive | 2003

Impfstoffzusammensetzung die lipooligosaccharid mit reduzierter phase variabilität enthält

Ralph Biemans; Philippe Denoel; Christiane GlaxoSmithKline Biologicals s.a Feron; Carine Goraj; Michael Paul Jennings; Jan GlaxoSmithKline Biologicals S.A. Poolman; Vincent GlaxoSmithKline Biologicals s.a Weynants

Collaboration


Dive into the Jan GlaxoSmithKline Biologicals S.A. Poolman's collaboration.

Researchain Logo
Decentralizing Knowledge